Positive results from the RETAIN-2 trial demonstrate that a response-adapted bladder-preservation approach involving neoadjuvant chemoimmunotherapy can be considered in select patients
Association for Diagnostics and Laboratory Medicine
The statement calls on Congress and federal agencies to modernize existing laboratory regulations and to implement policies to ensure that AI clinical systems are safe and effective
Routine PSMA PET/CT scans could help doctors select the best treatments for long-term outcomes in patients with recurring prostate cancer after surgical removal of the prostate
CAP authors outline how genomic, transcriptomic, and epigenetic profiling can support pathologists when conventional histology and immunohistochemistry fall short, particularly in cancers of unknown primary
The BioPathNet platform scans biomedical data networks to generate testable hypotheses that could support biomarker discovery and diagnostic development
There has been a lasting and disproportionate impact of the COVID-19 pandemic on diagnosis rates for conditions including depression, asthma, and osteoporosis
The research could help develop representative biomarkers and treatment strategies—bringing more precise and effective health care to millions of people
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.